Abstract
BackgroundVancomycin is commonly used for treatment of severe Gram+ neonatal infections. Currently, even with the use of optimized dosing regimens and therapeutic drug monitoring (TDM), target attainment rates are abominable,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have